Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
Wednesday, July 1, 2009 - 13:56
in Health & Medicine
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. The study is published in the July edition of the journal Molecular Endocrinology. This new study by Edward Filardo, MD, and his research team further supports earlier published work by the group that linked the transmembrane receptor, GPR30/GPER-1, to specific estrogen binding, rapid estrogen signaling and breast cancer metastasis.
Read the whole article on Physorg
More from Physorg
Related
- Newly appreciated membrane estrogen receptor important therapeutic target for breast cancerWed, 1 Jul 2009, 14:57:36 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT
- Estrogen pills can benefit women with metastatic breast cancerThu, 11 Dec 2008, 11:59:33 EST
- Hormone mix could cut breast cancer risk and treat symptoms of menopauseMon, 19 Oct 2009, 17:43:30 EDT
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT